Mkts

Vanda Pharmaceuticals Inc.

NASDAQ: VNDA
$3.44-0.23 (-6.13%)
As of Nov 20, 4:00 PM ET

Key statistics

Day range
3.423.81
52-week range
3.569.94
Today
Open3.63
Previous close3.44
Volume1.05M
Valuation
Market cap226.37M
P/E ratio—
EPS (TTM)-4.62
Income & risk
Dividend / yield—
Beta0.72
Avg volume1.04M
Discussion

VNDA News

Stories mentioning VNDA from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue51,71857,21656,25852,59050,04153,18547,65150,474
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development28,43529,00622,56321,99035,71219,84016,77616,661
Sales General & Admin68,36162,97860,27364,61650,08439,28237,57339,474
Total Operating Expenses
Operating Income (Loss)(50,224)(40,353)(31,284)(38,503)(41,028)(10,279)(11,000)(10,146)
Interest Income
Interest Expense
Other Expense
Pretax Income(48,424)(38,002)(28,390)(34,887)(37,368)(6,497)(6,244)(5,516)
Tax Provision143.00103,185(5,804)(7,680)(7,874)(1,585)(920.00)(998.00)
Net Income (Loss)(48,567)(141,187)(22,586)(27,207)(29,494)(4,912)(5,324)(4,518)
Earnings Per Share (Basic)(0.82)(2.40)(0.38)(0.46)(0.50)(0.08)(0.09)(0.08)
Earnings Per Share (Diluted)(0.82)(2.40)(0.38)(0.46)(0.50)(0.08)(0.09)(0.08)
Weighted Average Shares Outstanding (Basic)59,46058,93059,09158,99458,52858,14958,26258,221
Weighted Average Shares Outstanding (Diluted)59,46058,93059,09158,99458,52858,14958,26258,221

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About VNDA

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is a stock listed on the Nasdaq Stock Market under the ticker symbol VNDA. It last traded at $3.44 (Nov 20, 2026, 4:00 PM ET), down 6.1% on the day. That gives Vanda Pharmaceuticals a market capitalisation of $226.4M.

Over the past 52 weeks VNDA has traded between $3.56 and $9.94.

Revenue for the quarter ended Mar 31, 2026 was $51.7M; a net loss of $48.6M. Revenue was up 3.4% from $50.0M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$51.7M-$48.6M-93.9%
Dec 31, 2025$57.2M-$141.2M-246.8%
Sep 30, 2025$56.3M-$22.6M-40.1%
Jun 30, 2025$52.6M-$27.2M-51.7%

From Vanda Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…